XML 18 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash Flows from Operating Activities:    
Net income $ 77,677 $ 45,921
Amounts to reconcile net income to net cash flows provided by operating activities:    
Provision (benefit) for deferred income taxes (598) 244
Depreciation and amortization 55,182 56,969
Amortization of deferred financing costs 2,432 2,854
Impairment and other charges   2,890
Loss on repurchase of warrants   20,246
Write-off of deferred financing costs   1,928
Stock-based compensation expense 3,062 3,057
Changes in:    
Trade receivables 2,465 (23,324)
Accounts payable and accrued liabilities (16,638) (29,104)
Other assets and liabilities 3,320 (2,425)
Net cash flows provided by operating activities 126,902 79,256
Cash Flows from Investing Activities:    
Purchases of property and equipment (55,878) (38,818)
Proceeds from sale of Peterson LOI 6,785 10,000
Investment in Gaylord Rockies joint venture (31,944)  
Increase in restricted cash and cash equivalents (7,611) (7,860)
Other investing activities (1,900) 340
Net cash flows used in investing activities (90,548) (36,338)
Cash Flows from Financing Activities:    
Net borrowings (repayments) under credit facility 67,500 (246,000)
Repayments under term loan B (2,000) (2,000)
Issuance of senior notes   400,000
Repayment of note payable related to purchase of AC Hotel (6,000)  
Repurchase of common stock warrants   (154,681)
Deferred financing costs paid   (10,723)
Repurchase of Company stock for retirement (24,811)  
Payment of dividend (74,648) (62,070)
Proceeds from exercise of stock options 1,142 1,430
Payment of tax withholdings for share-based compensation (3,087) (3,646)
Other financing activities (9) (317)
Net cash flows used in financing activities (41,913) (78,007)
Net change in cash and cash equivalents (5,559) (35,089)
Cash and cash equivalents - unrestricted, beginning of period 56,291 76,408
Cash and cash equivalents - unrestricted, end of period $ 50,732 $ 41,319